Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
McKinsey
Medtronic
Harvard Business School
McKesson

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

DICYCLOMINE HYDROCHLORIDE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Dicyclomine Hydrochloride patents expire, and what generic alternatives are available?

Dicyclomine Hydrochloride is a drug marketed by Lannett, Mylan, Pioneer Pharms, Sun Pharm Industries, Watson Labs, West Ward, Akorn Inc, Am Regent, Apc Pharms Llc, Custopharm Inc, Dr Reddys, Fresenius Kabi Usa, Nexus Pharms, Slate, Sungen Pharma, Alpharma Us Pharms, Generics, Hikma Pharms, and West-ward Pharms Int. and is included in twenty-six NDAs.

The generic ingredient in DICYCLOMINE HYDROCHLORIDE is dicyclomine hydrochloride. There are four drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the dicyclomine hydrochloride profile page.

Summary for DICYCLOMINE HYDROCHLORIDE
Drug patent expirations by year for DICYCLOMINE HYDROCHLORIDE
Pharmacology for DICYCLOMINE HYDROCHLORIDE
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for DICYCLOMINE HYDROCHLORIDE
Synonyms for DICYCLOMINE HYDROCHLORIDE
(1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(diethylamino)ethyl ester, hydrochloride
(1,1'-Bicyclohexyl)-1-carboxylic acid, 2-(diethylamino)ethyl ester, hydrochloride (1:1)
(2-(((1,1'-Bicyclohexyl)-1-ylcarbonyl)oxy)ethyl)diethylammonium chloride
(BICYCLOHEXYL)-1-CARBOXYLIC ACID, 2-(DIETHYLAMINO)ETHYL ESTER, HYDROCHLORIDE
[1,1-Bicyclohexyl]-1-carboxylic acid 2-(diethylamino)ethyl ester hydrochloride
[1,1'-Bicyclohexyl]-1-carboxylic acid, 2-(diethylamino)ethyl ester, hydrochloride (1:1)
[Bicyclohexyl]-1-carboxylic acid diethylaminoethyl ester
067D925
1-Cyclohexyl-cyclohexan-1-carbonsaeure-2-diaethylaminoaethylester hydrochlorid
1-Cyclohexyl-cyclohexan-1-carbonsaeure-2-diaethylaminoaethylester hydrochlorid [German]
2-(Diethylamino)ethyl (bicyclohexyl)-1-carboxylate hydrochloride
2-(Diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate hydrochloride
2-(Diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate hydrochloride; [1,1-Bicyclohexyl]-1-carboxylic acid 2-(diethylamino)ethyl ester hydrochloride
2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate;hydrochloride
2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate hydrochloride
2-(diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylate, chloride
2-(diethylamino)ethyl bi(cyclohexane)-1-carboxylate hydrochloride
2-diethylaminoethyl 1-cyclohexylcyclohexane-1-carboxylate hydrochloride
2-Diethylaminoethyl bicyclohexyl-1-carboxylate hydrochloride
67-92-5
77-19-0 (Parent)
79988-11-7
AB1004835
AC1L9B0G
AI3-18105
AKOS015950777
Ametil
AN-23770
Antispas
Atumin
Benacol
Bentomine
Bentyl (TN)
BENTYL PRESERVATIVE FREE
beta-Diethylaminoethyl 1-cyclohexylcyclohexanecarboxylate hydrochloride
beta-Diethylaminoethyl-1-cyclohexylcyclohexanecarboxylate hydrochloride
beta-Diethylaminoethyl-1-cyclohexylhexahydrobenzoate hydrochloride
Bis(cyclohexyl)carboxylic acid diethylaminoethyl ester hydrochloride
C19H35NO2.HCl
CCG-39149
CHEBI:4515
CHEMBL1200479
Cloridrato dell'estere beta-dietil aminoetilico dell'acido cicloesil-1-cicloesancarbossilico
CPD000058440
CQ903KQA31
D 7909
D00717
Dibent
Dicyclomine Hcl
Dicyclomine hydrochloride (JAN/USP)
Dicyclomine hydrochloride (preservative-free)
Dicyclomine hydrochloride [USAN]
Dicyclomine hydrochloride [USP]
Dicyclomine hydrochloride, >=99% (TLC), powder
Dicyclomine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Dicycloverin hydrochloride
Dicycloverine HCl
Dicycloverine hydrochloride
Dicycloverine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Diethylaminocarbethoxybicyclohexyl hydrochloride
Diocyl hydrochloride
DTXSID0058778
Dyspas
EINECS 200-671-1
EU-0100432
FT-0624744
HMS1568I17
HMS1920E22
Icramin
Kolantyl hydrochloride
LP00432
LS-43730
LS-56641
Mamiesan
MCULE-7810636561
MFCD00079158
MLS000028426
MLS001074064
MolPort-003-666-161
NC00504
NCGC00093853-01
NCGC00093853-02
NCGC00093853-03
NCGC00093853-04
NCGC00093853-05
NCGC00261117-01
NSC 404381
NSC-756727
NSC756727
Opera_ID_272
Oxityl-P
Pharmakon1600-01500240
Prestwick_891
Procyclomin
REGID_for_CID_441344
SAM002554894
Sawamin
SBB058148
SCHEMBL41670
SMR000058440
Spasmoject
SPECTRUM1500240
SR-01000003056
SR-01000003056-2
SR-01000003056-7
ST51014989
Stannitol
SW197012-3
Tox21_500432
UNII-CQ903KQA31
Wyovin hydrochloride

US Patents and Regulatory Information for DICYCLOMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 084285-001 Approved Prior to Jan 1, 1982 AB RX No No   Start Trial   Start Trial   Start Trial
Generics DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride SYRUP;ORAL 040169-001 Mar 24, 2005 RX No Yes   Start Trial   Start Trial   Start Trial
Watson Labs DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride TABLET;ORAL 084361-001 Feb 6, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
West Ward DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 040204-001 Feb 28, 1997 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride CAPSULE;ORAL 084505-001 Oct 21, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Dr Reddys DICYCLOMINE HYDROCHLORIDE dicyclomine hydrochloride INJECTABLE;INJECTION 080614-001 Feb 11, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Moodys
Baxter
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.